Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4′-Substituted triclosan derivatives
- 1 December 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (23) , 5247-5252
- https://doi.org/10.1016/j.bmcl.2005.08.044
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Microbial Type I Fatty Acid Synthases (FAS): Major Players in a Network of Cellular FAS SystemsMicrobiology and Molecular Biology Reviews, 2004
- Antimalarial drug discovery: efficacy models for compound screeningNature Reviews Drug Discovery, 2004
- Metabolic maps and functions of the Plasmodium falciparum apicoplastNature Reviews Microbiology, 2004
- Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan for Malarial Enoyl Acyl Carrier Protein ReductaseJournal of Biological Chemistry, 2002
- Malaria in 2002Nature, 2002
- Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of Apicomplexan Fab IInternational Journal for Parasitology, 2001
- Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and HexachloropheneJournal of Biological Chemistry, 2000
- Mechanism of Triclosan Inhibition of Bacterial Fatty Acid SynthesisJournal of Biological Chemistry, 1999
- Triclosan targets lipid synthesisNature, 1998